A federal appeals court has reinstated a False Claims Act case alleging Gilead Sciences Inc. received billions in government reimbursements for HIV drugs that weren’t qualified under the Food and Drug Administration.

The U.S. Court of Appeals for the Ninth Circuit on Friday reversed a lower court that found ex-Gilead employees Jeff and Sherilyn Campie failed to state plausible claims in their suit brought on behalf of the government.